Patents-Review.com
🔗 Permalink
Assignee profile:

ANGIOLAB, INC.

City:

Daejeon

Country:

South Korea

Published Applications:

9

Last publication date:

2024-02-08

Patent Grants:

9

Last grant date:

2024-09-03

Top Inventors for applications by ANGIOLAB, INC.

These are the the leading inventors for applications assigned to ANGIOLAB, INC.:

Recent patent applications by ANGIOLAB, INC.

ANGIOLAB, INC. based in Daejeon, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-02-08 ✅ Patent 12,076,359 granted on 2024-09-03
US20240041965A1
Human necessities

Pharmaceutical composition comprising a fraction of leaf extract

 #2 | 2021-02-25 ✅ Patent 11,224,629 granted on 2022-01-18
US20210052686A1
Human necessities

Fraction of Melissa leaf extract having angiogenesis and MMP inhibitory activities, and composition comprising the same

 #3 | 2018-05-08 ✅ Patent 9,962,331 granted on 2018-05-08
US10832713
Human necessities

Composition containing horse chestnut extract

 #4 | 2010-11-04 ✅ Patent 10,894,071 granted on 2021-01-19
US20100278914A1
Human necessities

Fraction of melissa leaf extract having angiogenesis and MMP inhibitory activities, and composition comprising the same

 #5 | 2009-08-11 ✅ Patent 7,572,831 granted on 2009-08-11
US10838853
-

Composition containing chalcone

 #6 | 2009-02-03 ✅ Patent 7,485,327 granted on 2009-02-03
US10460951
-

Composition comprising leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity

 #7 | 2008-08-07 ✅ Patent 9,155,773 granted on 2015-10-13
US20080187606A1
Human necessities

Antiobesity composition

 #8 | 2006-11-02 ✅ Patent 7,482,027 granted on 2009-01-27
US20060246157A1
Human necessities

Composition for the prevention or treatment of diseases associated with angiogenesis

 #9 | 2005-03-03 ✅ Patent 7,163,805 granted on 2007-01-16
US20050048627A1
Chemistry; metallurgy

Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein

Also check out ANGIOLAB, INC.'s (Daejeon, South Korea) applicant profile with 2 patent applications submitted.

AssigneeID:

296464 ⎘